Reaction
Ulna Fracture reporting signals
As of the last recalculation, Ulna Fracture appears in 980 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 51.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 195 | 51.0 | 51.1 |
| Risedronate Sodium | 45 | 32.2 | 32.2 |
| Emtricitabine And Tenofovir Alafenamide | 15 | 28.5 | 28.6 |
| Alendronate Sodium Tablet | 22 | 25.8 | 25.8 |
| Romosozumab-Aqqg | 15 | 23.8 | 23.8 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 9 | 21.4 | 21.4 |
| Zoledronic Acid | 28 | 15.2 | 15.2 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 12 | 14.2 | 14.2 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 6 | 12.7 | 12.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 26 | 12.4 | 12.4 |
| Teriparatide | 41 | 8.0 | 8.0 |
| Denosumab | 69 | 7.7 | 7.7 |
| Tenofovir Disoproxil Fumarate | 11 | 7.1 | 7.1 |